Fig. 6.

Effect of AgNPs on mRNA expression levels of (A) inducible nitric oxide synthase (iNOS), (B) apurinic/apyrimidinic endo deoxyribonuclease 1 (APE1), (C) NAD (P) H quinone dehydrogenase 1 (NQO1), (D) Bcl-2-associated X (BAX), (E) B cell lymphoma 2 (Bcl-2), (F) transforming growth factor (TGF-B), and alpha-smooth muscle actin (α-SMA) expression levels of the control and AgNP-treated groups after 30 days of AgNP exposure. Data are expressed as mean ± SEM (n = 7). Subscript letters (a, b, and c) indicate that means with different superscripts are significantly different at p < 0.05